International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.

Slides:



Advertisements
Similar presentations
Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Advertisements

ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Your name Institution/organization Meeting Date. Introduction.
Evaluation of a new Health Code requirement for discharging infectious tuberculosis patients from NYC hospitals Michelle M. Macaraig, MPH Assistant Director.
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
Improving diagnosis TB laboratory strengthening.
MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
KEY CHANGES IN THE NEW NTBLCP GUIDELINES
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Integrating TB into PWID Services in Indonesia The Works in Progress Dr Siti Nadia, NAP Manager; Dr Dyah Erti Mustikawati, NTP Manager Melbourne AIDS Conference.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Monitoring and Evaluation Module 12 – March 2010.
The Cohort Review Process The Cohort Review Process Kim Field RN, MSN WA State DOH Tuberculosis Program.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
Monitoring Drug Resistant Tuberculosis Treatment in Brazil through an Innovative Web-based Information System Dr. Luis Gustavo Bastos Management Sciences.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Progress of the Singapore TB Elimination Programme (STEP)
ISTC The Indonesian Experience Erlina Burhan Indonesian Society of Respirology ISTC Task Force Indonesian Medical Association.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Large Hospitals DEWG – Group Work Report. Participants Indonesia Philippines South Africa Viet Nam Korea China Partners: KNCV, WHO, Gates.
Unit 12: Reporting & Recording Botswana National Tuberculosis Programme Manual Training for Medical Officers.
International Health Policy Program -Thailand Policy decision on multi drug resistant(MDR), extreme drug resistant(XDR) tuberculosis screening: How it.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Kamwokya Christian Caring Community The Role of Treatment Supporters In TB Management. Being a Paper Presented at The XVIII International AIDS Conference,
Tuberculosis control in Suriname Situational analysis.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Predictors of Failure in Timely TB Treatment Completion, United States Carla Winston,PhD TB PEN Focal Point Open Forum June 5,
Roundtable. Detection and treatment of TB Andrew Black.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Monitoring and Evaluation Frameworks
TB- HIV Collaborative activities in Romania- may 2006 status
World Tuberculosis Day 2014
This is an archived document.
PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED
Authors: Archana Trivedi1, Sarabjit Chadha1, Suneetha Nareddy2, Asra Farheen, J Suresh 3, Karuna Sagili1 1International Union Against Tuberculosis and.
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Public-Public Mix for DOTS Indonesia’s Experience
Implementing a TB-Control Program in Prisons: The Basics
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
Success and failure in TB surveillance in Hungary
5th edition NTP MANUAL OF PROCEDURES Introduction and Highlights
From TB control to integrated respiratory disease control
Goal Objectives Expected Outcomes
National Tuberculosis Control Program Department of Health Philippines Dr. Vivian S. Lofranco Medical Specialist IV.
Cheng shiming National TB Center in China May,3, 2004
TB epidemiology in Bulgaria
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Presentation transcript:

International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo 2, F. Yunus 1, L. Chen 3, B. M. Djojonegoro 3, P. C. Hopewell 3, F. Mulyani 4, D. E. Mustikawati 5 1 The Indonesian Society of Respirology, Jakarta, Indonesia; 2 Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; 3 American Thoracic Society, New York, New York, and Curry International Tuberculosis Center, UCSF, Oakland, USA; 4 DKI Jakarta Provincial Health Office, Jakarta, Indonesia; 5 Subdirectorate of Tuberculosis Control, Ministry of Health, Jakarta, Indonesia Background: Most pulmonologists in Jakarta practice in private hospitals and treat tuberculosis (TB) patients. With the introduction of the International Standards of Care (ISTC) and DOTS, pulmonologists are expected to implement the standards in their practice regardless of limitations in their private practice settings. To improve case notification and monitoring of treatment outcomes, the Indonesian Society of Respirology (PDPI) implemented a project in which selected private pulmonologists agreed to manage patients in accordance with the ISTC and National TB Program (NTP) guidelines. Methods: To validate information from TB case reporting through the PDPI project, we reviewed medical records from the practices of 21 pulmonologists from 16 private hospitals in East, South, and Central Jakarta. Abstractors with TB clinical background collected data from 258 TB patients, diagnosed between October-December 2010, with expected treatment completion by June We developed a questionnaire and scoring system related to diagnosis, therapy, monitoring, and outcomes of TB treatment to assess ISTC implementation. Discussion: Most of the pulmonologists performed appropriate ISTC implementation in their private practice. The high number of patients who defaulted from treatment may indicate the lack of patient education given by pulmonologists or the need of a better linkage system among private providers and the local Health Office to ensure continued TB treatment of patients. Result: We evaluated 11 of 21 standards: 4 diagnostic, 5 treatment, 1 co-morbidity, and 1 public health standards. Four pulmonologists (19%) adhered to all standards, 8 (38%) adhered to 10 of 11 standards, 1 met only 8 of 12 standards, while the rest met varied numbers of standards. Standard 21 is implemented by all pulmonologists and Standards 4 and 8 are implemented well by >80% of pulmonologists. Standard 11 was least implemented, with no or partial implementation by 90% of pulmonologists. Of 258 TB cases, 65% were successfully treated, 1% failed, 1% died, 28% defaulted from treatment, and 5% transferred out to another facility. StandardDescriptionImplementation on Patients Implement -ation Score* 2Two sputum specimens104 of 219 (47%).70% 3Appropriate specimen submitted (extrapulmonary TB) 21 of 39 (54%).78% 4All with suspect chest X- ray submit sputum 154 of 211 (73%).95% 5Diagnosis of sputum smear negative pulmonary TB 50 of 94 (53%)52% 7Appropriate regimen and adherence assessment 230 of 231 (100%) with no history of prior TB and 14 of 25 with TB history (56%) given appropriate regimen. 56% 8Appropriate first line regimen 230 of 231 (100%) with no history of prior TB. 84% 10Monitoring of response to therapy 33 of 64 with positive smear at diagnosis (52%) converted, 6 (9%) did not convert, and 25 (39%) unknown. 72% 11Assessment of drug resistance 2 of 25 with TB history (15%) had culture and susceptibility test. 8% 13Written record160 of 219 pulmonary TB patients (73%) had diagnostic smear. Of those smear +, 61% had monitoring smear. All but 1 patient had record of drug regimen. 11 were noted with side effects. 39% 17Co-morbid conditions24 patients with co- morbidities; diabetes mellitus was most common at 18 (75%) 24% 21Reporting of all TB patients All were reported to local health office and according to NTP policy 100% *Percent of pulmonologists who implemented the standard for >=50% of their patients Excerpt of Abstraction ToolStandards and Their Implementation OutcomeN (%) Cured70 (27) Completed97 (38) Failed2 (1) Deceased3 (1) Transferred out14 (5) Defaulted72 (28) Patient Outcome